These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 28492003)

  • 21. Preliminary, dermatologic first step criteria for lupus erythematosus and second step criteria for systemic lupus erythematosus.
    Beutner EH; Blaszczyk M; Jablonska S; Chorzelski TP; White D; Wolska H; Davis B
    Int J Dermatol; 1993 Sep; 32(9):645-51. PubMed ID: 8407091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The natural history of pediatric-onset discoid lupus erythematosus.
    Arkin LM; Ansell L; Rademaker A; Curran ML; Miller ML; Wagner A; Kenner-Bell BM; Chamlin SL; Mancini AJ; Klein-Gitelman M; Paller AS
    J Am Acad Dermatol; 2015 Apr; 72(4):628-33. PubMed ID: 25648823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular Profiling of Cutaneous Lupus Lesions Identifies Subgroups Distinct from Clinical Phenotypes.
    Berthier CC; Tsoi LC; Reed TJ; Stannard JN; Myers EM; Namas R; Xing X; Lazar S; Lowe L; Kretzler M; Gudjonsson JE; Kahlenberg JM
    J Clin Med; 2019 Aug; 8(8):. PubMed ID: 31426521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IL-17 in cutaneous lupus erythematosus.
    Tanasescu C; Balanescu E; Balanescu P; Olteanu R; Badea C; Grancea C; Vagu C; Bleotu C; Ardeleanu C; Georgescu A
    Eur J Intern Med; 2010 Jun; 21(3):202-7. PubMed ID: 20493423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The classification and diagnosis of cutaneous lupus erythematosus.
    Kuhn A; Landmann A
    J Autoimmun; 2014; 48-49():14-9. PubMed ID: 24486120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cutaneous Lupus Erythematosus Patients With a Negative Antinuclear Antibody Meeting the American College of Rheumatology and/or Systemic Lupus International Collaborating Clinics Criteria for Systemic Lupus Erythematosus.
    Tarazi M; Gaffney RG; Kushner CJ; Chakka S; Werth VP
    Arthritis Care Res (Hoboken); 2019 Nov; 71(11):1404-1409. PubMed ID: 31058462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determining risk factors for developing systemic lupus erythematosus in patients with discoid lupus erythematosus.
    Chong BF; Song J; Olsen NJ
    Br J Dermatol; 2012 Jan; 166(1):29-35. PubMed ID: 21910708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Response letter to 'chronic cutaneous lupus erythematosus induced by 5-fluorouracil'.
    Borucki R; Werth VP
    Expert Rev Clin Pharmacol; 2020 Aug; 13(8):919-920. PubMed ID: 32643978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic implications of active discoid lupus erythematosus and malar rash at the time of diagnosis of systemic lupus erythematosus: Results from a prospective cohort study.
    Drucker AM; Su J; Mussani F; Siddha SK; Gladman DD; Urowitz MB
    Lupus; 2016 Apr; 25(4):376-81. PubMed ID: 26453664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dermoscopic Features of Acute, Subacute, Chronic and Intermittent Subtypes of Cutaneous Lupus Erythematosus in Caucasians.
    Żychowska M; Reich A
    J Clin Med; 2022 Jul; 11(14):. PubMed ID: 35887849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The value of lymphocytopenia as a marker of systemic involvement in cutaneous lupus erythematosus.
    Wenzel J; Bauer R; Uerlich M; Bieber T; Boehm I
    Br J Dermatol; 2002 May; 146(5):869-71. PubMed ID: 12000386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comprehensive review of immune-mediated dermatopathology in systemic lupus erythematosus.
    Li Q; Wu H; Liao W; Zhao M; Chan V; Li L; Zheng M; Chen G; Zhang J; Lau CS; Lu Q
    J Autoimmun; 2018 Sep; 93():1-15. PubMed ID: 30017673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Response of discoid and subacute cutaneous lupus erythematosus to recombinant interferon alpha 2a.
    Nicolas JF; Thivolet J; Kanitakis J; Lyonnet S
    J Invest Dermatol; 1990 Dec; 95(6 Suppl):142S-145S. PubMed ID: 2258631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cutaneous lupus erythematosus. Part 1: clinical manifestations and classification].
    Kuhn A; Gensch K; Ständer S; Bonsmann G
    Hautarzt; 2006 Mar; 57(3):251-67; quiz 268. PubMed ID: 16501922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Photoprovocation in cutaneous lupus erythematosus: a multicenter study evaluating a standardized protocol.
    Kuhn A; Wozniacka A; Szepietowski JC; Gläser R; Lehmann P; Haust M; Sysa-Jedrzejowska A; Reich A; Oke V; Hügel R; Calderon C; de Vries DE; Nyberg F
    J Invest Dermatol; 2011 Aug; 131(8):1622-30. PubMed ID: 21593767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subacute cutaneous lupus erythematosus.
    David-Bajar KM
    J Invest Dermatol; 1993 Jan; 100(1):2S-8S. PubMed ID: 8423385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Classification of lupus erythematosus based upon Japanese patients.
    Tsuchida T
    Autoimmun Rev; 2009 May; 8(6):453-5. PubMed ID: 19162249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Practice-based differences in paediatric discoid lupus erythematosus.
    Arkin LM; Buhr K; Brandling-Bennett H; Chiu Y; Chong B; Curran M; Hunt R; Paller AS; Werth VP; Klein-Gitelman M; von Scheven E; Ardalan K
    Br J Dermatol; 2019 Oct; 181(4):805-810. PubMed ID: 30768778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topical tacrolimus and pimecrolimus in the treatment of cutaneous lupus erythematosus: an evidence-based evaluation.
    Tzellos TG; Kouvelas D
    Eur J Clin Pharmacol; 2008 Apr; 64(4):337-41. PubMed ID: 18157526
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.